Nitin A Pagedar1, Nicholas Kendell1, Alan J Christensen2, Timothy A Thomsen3, Michaela Gist1, Aaron T Seaman3. 1. Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA. 2. Department of Psychology and Brain Sciences, University of Iowa, Iowa City, Iowa, USA. 3. Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
Abstract
BACKGROUND: Survivorship is a critical part of head and neck cancer (HNC) care. In order to design better processes, we assessed care provided to long-term HNC survivors and their priorities for ongoing care. METHODS: A survey was provided to HNC survivors at clinic appointments, including our HNC survivorship clinic. Questions focused on priorities for care in the otolaryngology clinic, types of care provided, and opioid use. RESULTS: Of 168 respondents, the most common priority for survivors was surveillance for recurrence (first priority in 75%), with general health the next most common (8%). Few respondents reported active primary care involvement in survivorship. About 10% of patients reported current opioid use. CONCLUSION: Survivors face a large burden of symptoms and deficits, but our data show that most survivors focus on recurrence. Few survivors reported recall of survivorship care plan delivery or discussing cancer care needs with primary care providers.
BACKGROUND: Survivorship is a critical part of head and neck cancer (HNC) care. In order to design better processes, we assessed care provided to long-term HNC survivors and their priorities for ongoing care. METHODS: A survey was provided to HNC survivors at clinic appointments, including our HNC survivorship clinic. Questions focused on priorities for care in the otolaryngology clinic, types of care provided, and opioid use. RESULTS: Of 168 respondents, the most common priority for survivors was surveillance for recurrence (first priority in 75%), with general health the next most common (8%). Few respondents reported active primary care involvement in survivorship. About 10% of patients reported current opioid use. CONCLUSION: Survivors face a large burden of symptoms and deficits, but our data show that most survivors focus on recurrence. Few survivors reported recall of survivorship care plan delivery or discussing cancer care needs with primary care providers.
Authors: Aaron T Seaman; Kimberly Dukes; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Veléz-Bermúdez; Robert J Volk; Nitin A Pagedar Journal: Patient Educ Couns Date: 2018-04-22
Authors: Callie Berkowitz; Deborah H Allen; Jennifer Tenhover; Leah L Zullig; John Ragsdale; Jonathan E Fischer; Kathryn I Pollak; Bridget F Koontz Journal: J Cancer Educ Date: 2018-12 Impact factor: 2.037
Authors: Larissa Nekhlyudov; Christina Lacchetti; Nancy B Davis; Thomas Q Garvey; David P Goldstein; J Chris Nunnink; Jose I Ruades Ninfea; Andrew L Salner; Talya Salz; Lillian L Siu Journal: J Clin Oncol Date: 2017-02-27 Impact factor: 44.544
Authors: Melissa Henry; Laura-Anne Habib; Matthew Morrison; Ji Wei Yang; Xuejiao Joanna Li; Shiru Lin; Anthony Zeitouni; Richard Payne; Christina MacDonald; Alexander Mlynarek; Karen Kost; Martin Black; Michael Hier Journal: Palliat Support Care Date: 2013-10-24
Authors: Meredith Giuliani; Maurene McQuestion; Jennifer Jones; Janet Papadakos; Lisa W Le; Nour Alkazaz; Terry Cheng; John Waldron; Pamela Catton; Jolie Ringash Journal: Head Neck Date: 2016-02-19 Impact factor: 3.147
Authors: Meredith Giuliani; Robin Milne; Maurene McQuestion; Lorna Sampson; Lisa W Le; Jennifer Jones; Terry Cheng; John Waldron; Jolie Ringash Journal: Oral Oncol Date: 2017-06-23 Impact factor: 5.337
Authors: Ezra E W Cohen; Samuel J LaMonte; Nicole L Erb; Kerry L Beckman; Nader Sadeghi; Katherine A Hutcheson; Michael D Stubblefield; Dennis M Abbott; Penelope S Fisher; Kevin D Stein; Gary H Lyman; Mandi L Pratt-Chapman Journal: CA Cancer J Clin Date: 2016-03-22 Impact factor: 508.702
Authors: Aaron T Seaman; Kristen L Seligman; Khanh K Nguyen; Zaid Al-Qurayshi; Nicholas D Kendell; Nitin A Pagedar Journal: Cancer Date: 2021-08-30 Impact factor: 6.860